FFTY vs. BIS
FFTY (Innovator IBD 50 ETF) and BIS (ProShares UltraShort Nasdaq Biotechnology) are both exchange-traded funds - FFTY is a Large Cap Growth Equities fund tracking the IBD 50 Index, while BIS is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (-200%). Both are passively managed. Over the past 10 years, FFTY returned 7.91%/yr vs -26.06%/yr for BIS. At a correlation of -0.59, they often move in opposite directions. FFTY charges 0.80%/yr vs 0.95%/yr for BIS.
Performance
FFTY vs. BIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FFTY achieves a 20.94% return, which is significantly higher than BIS's -17.93% return. Over the past 10 years, FFTY has outperformed BIS with an annualized return of 7.91%, while BIS has yielded a comparatively lower -26.06% annualized return.
FFTY
- 1D
- -4.21%
- 1M
- 5.39%
- YTD
- 20.94%
- 6M
- 18.21%
- 1Y
- 36.43%
- 3Y*
- 21.26%
- 5Y*
- -0.44%
- 10Y*
- 7.91%
BIS
- 1D
- -1.74%
- 1M
- -10.00%
- YTD
- -17.93%
- 6M
- -14.94%
- 1Y
- -55.93%
- 3Y*
- -24.98%
- 5Y*
- -14.70%
- 10Y*
- -26.06%
FFTY vs. BIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FFTY Innovator IBD 50 ETF | 20.94% | 23.38% | 18.36% | 12.40% | -51.08% | 11.92% | 18.20% | 25.74% | -16.76% | 37.62% |
BIS ProShares UltraShort Nasdaq Biotechnology | -17.93% | -45.95% | 4.79% | -6.54% | -2.14% | -14.74% | -56.01% | -41.01% | 5.14% | -36.98% |
Correlation
The correlation between FFTY and BIS is -0.44, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.48 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.54 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.58 |
Correlation (All Time) Calculated using the full available price history since Apr 9, 2015 | -0.59 |
The correlation between FFTY and BIS shifts across timeframes, from -0.59 (all time) to -0.44 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FFTY vs. BIS — Risk / Return Rank
FFTY
BIS
FFTY vs. BIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator IBD 50 ETF (FFTY) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FFTY | BIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.40 | ||
| Sortino ratioReturn per unit of downside risk | +3.78 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 0.75 | +0.44 |
| Calmar ratioReturn relative to maximum drawdown | 1.57 | -1.02 | +2.59 |
| Martin ratioReturn relative to average drawdown | 4.14 | -1.39 | +5.53 |
Loading charts...
Drawdowns
FFTY vs. BIS - Drawdown Comparison
The maximum FFTY drawdown since its inception was -59.46%, smaller than the maximum BIS drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for FFTY and BIS.
Loading charts...
Drawdown Indicators
| FFTY | BIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.46% | -99.87% | +40.41% |
Max Drawdown (1Y)Largest decline over 1 year | -23.29% | -55.07% | +31.78% |
Max Drawdown (3Y)Largest decline over 3 years | -29.60% | -67.92% | +38.32% |
Max Drawdown (5Y)Largest decline over 5 years | -59.46% | -75.59% | +16.13% |
Max Drawdown (10Y)Largest decline over 10 years | -59.46% | -95.40% | +35.94% |
Current DrawdownCurrent decline from peak | -14.76% | -99.87% | +85.11% |
Average DrawdownAverage peak-to-trough decline | -22.34% | -90.04% | +67.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.82% | 41.32% | -32.50% |
Volatility
FFTY vs. BIS - Volatility Comparison
Innovator IBD 50 ETF (FFTY) and ProShares UltraShort Nasdaq Biotechnology (BIS) have volatilities of 13.44% and 13.79%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FFTY | BIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.44% | 13.79% | -0.35% |
Volatility (6M)Calculated over the trailing 6-month period | 28.50% | 32.10% | -3.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.99% | 40.51% | -4.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.63% | 43.80% | -14.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.67% | 46.26% | -18.59% |
FFTY vs. BIS - Expense Ratio Comparison
FFTY has a 0.80% expense ratio, which is lower than BIS's 0.95% expense ratio.
Dividends
FFTY vs. BIS - Dividend Comparison
FFTY's dividend yield for the trailing twelve months is around 1.11%, less than BIS's 5.61% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.61% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% | 0.00% |
FFTY Innovator IBD 50 ETF | 1.11% | 1.35% | 0.91% | 0.65% | 2.75% | 0.22% | 0.00% | 0.00% | 0.00% | 0.17% |
Frequently Asked Questions
FFTY and BIS have a correlation of -0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIS has higher volatility (13.79%) compared to FFTY (13.44%). In terms of maximum drawdown, FFTY dropped -59.46% vs BIS's -99.87%.
On 10-year performance, FFTY leads with 7.91% vs -26.06% for BIS. On fees, FFTY is cheaper at 0.80% per year. On volatility, FFTY has been the lower-risk option at 13.44%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FFTY has performed better with a 7.91% return vs -26.06%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FFTY is cheaper with a 0.80% expense ratio, compared with 0.95% for BIS.
BIS has the higher dividend yield at 5.61%, compared with 1.11% for FFTY.
FFTY is categorized as Large Cap Growth Equities, while BIS is Leveraged Equities. FFTY tracks IBD 50 Index, while BIS tracks NASDAQ Biotechnology Index (-200%). They also come from different issuers: Innovator and ProShares. Their fees differ too: 0.80% for FFTY and 0.95% for BIS.
FFTY currently has the higher Sharpe Ratio (1.02 vs -1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FFTY and BIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer